On 25 January 2019, 25 January 2019, 3 September 2015, 25 February 2020, 17 December 2020, 30 June 2016, 20 March 2019, 11 April 2016, 22 March 2021, 14 March 2016, 17 December 2020, 17 July 2017, 12 February 2020, 28 January 2019, 14 September 2017, 14 February 2017, 23 May 2018, 17 January 2014, 31 January 2019, 20 February 2017 and 17 December 2020, the rapporteur Member States, for the active substances 1-naphthylacetamide, 1-naphthylacetic acid, boscalid, esfenvalerate, eugenol, fenpyroximate, fluazifop-P, fluazinam, fluopyram, flutolanil, geraniol, malathion, penoxsulam, prohexadione, proquinazid, pyrethrins, pyridaben, pyrimethanil, spiroxamine, sulphur and thymol, respectively, informed the co-rapporteur Member States, the Commission and the European Food Safety Authority (the ‘Authority’) that they had assessed the admissibility of the applications pursuant to Article 3 of Implementing Regulation (EU) No 844/2012, and in particular the completeness and the timeliness, of each of the applications for renewal of the approval of each of those active substances and concluded that they were admissible. Those applications have been made public by the Authority pursuant to Article 5 of Implementing Regulation (EU) No 844/2012.
Recital 39, Regulation (EU) 2026/372
In forcesince 20 Feb 2026
- celex=32012R0844